AMERIPRISE FINANCIAL INC

Holdings History for Revance Therapeutics, Inc. - COM (RVNC)

Symbol: RVNC on Nasdaq
Investment type: Equity - Shares of Stock
Class: COM

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2024	0%	0%	$79.8K	15.4K	-152,568	-90.8%	$5.19	Q3 2024
6/30/2024	0%	0%	$432K	168K	-1,963	-1.16%	$2.57	Q2 2024
3/31/2024	0%	0%	$836K	170K	-8,192	-4.6%	$4.92	Q1 2024
12/31/2023	0%	+0%	$1.57M	178K	+52,284	+41.6%	$8.79	Q4 2023
9/30/2023	0%	0%	$1.44M	126K	-87,297	-41%	$11.47	Q3 2023
6/30/2023	0%	0%	$5.39M	213K	-67,866	-24.2%	$25.31	Q2 2023
3/31/2023	0%	+0%	$9.05M	281K	+46,713	+19.9%	$32.21	Q1 2023
12/31/2022	0%	+0%	$4.33M	234K	+66,207	+39.4%	$18.46	Q4 2022
9/30/2022	0%	+0%	$4.54M	168K	+24,797	+17.3%	$27.00	Q3 2022
6/30/2022	0%	+0%	$1.98M	143K	+8,009	+5.92%	$13.82	Q2 2022
3/31/2022			$1K	71			$14.08^*	Q1 2022
3/31/2022	0%	+0%	$2.64M	135K	+13,817	+11.4%	$19.50	Q1 2022
12/31/2021	0%	0%	$1.98M	121K	-44,531	-26.8%	$16.32	Q4 2021
9/30/2021	0%		$4.62M	166K	+11	+0.01%	$27.85	Q3 2021
6/30/2021	0%	+0%	$4.92M	166K	+16,043	+10.7%	$29.64	Q2 2021
3/31/2021	0%	0%	$4.19M	150K	-9,904	-6.2%	$27.95	Q1 2021
12/31/2020	0%	+0%	$4.53M	160K	+27,349	+20.6%	$28.34	Q4 2020
9/30/2020	0%	0%	$3.33M	132K	-15,128	-10.2%	$25.14	Q3 2020
6/30/2020	0%	0%	$3.61M	148K	-48,206	-24.6%	$24.42	Q2 2020
3/31/2020	0%	0%	$2.9M	196K	-21,567	-9.92%	$14.80	Q1 2020
12/31/2019	0%	+0%	$3.55M	217K	+70,404	+47.9%	$16.34	Q4 2019
9/30/2019	0%	+0%	$1.91M	147K	+28,762	+24.3%	$13.00	Q3 2019
6/30/2019	0%	0%	$1.53M	118K	-17,696	-13%	$12.97	Q2 2019
3/31/2019	0%	+0%	$2.14M	136K	+105,265	+344%	$15.75	Q1 2019
12/31/2018	0%	+0%	$617K	30.6K	+1,123	+3.8%	$20.14	Q4 2018
9/30/2018	0%	+0%	$733K	29.5K	+2,402	+8.86%	$24.84	Q3 2018
6/30/2018	0%	0%	$744K	27.1K	-28,605	-51.3%	$27.44	Q2 2018
3/31/2018	0%	0%	$1.72M	55.7K	-8,897	-13.8%	$30.82	Q1 2018
12/31/2017	0%	+0%	$2.31M	64.6K	+41,630	+181%	$35.74	Q4 2017
9/30/2017	0%	+0%	$634K	23K	+80	+0.35%	$27.58	Q3 2017
6/30/2017	0%	+0%	$604K	22.9K	+225	+0.99%	$26.37	Q2 2017
3/31/2017	0%		$472K	22.7K			$20.81	Q1 2017
12/31/2016	0%	+0%	$469K	22.7K	+22,679	NEW	$20.68	Q4 2016
6/30/2016		0%	$0	0	-13,815	-100%		Q2 2016
3/31/2016	0%	0%	$241K	13.8K	-28,142	-67.1%	$17.44	Q1 2016
12/31/2015	0%	+0%	$1.43M	42K	+41,957	NEW	$34.15	Q4 2015
3/31/2015		0%	$0	0	-252,494	-100%		Q1 2015
12/31/2014	0%	+0%	$4.28M	252K	+18,002	+7.68%	$16.94	Q4 2014
9/30/2014	0%	+0%	$4.53M	234K	+50,271	+27.3%	$19.33	Q3 2014
6/30/2014	0%	+0%	$6.26M	184K	+19,755	+12%	$34.00	Q2 2014
3/31/2014	0%	+0%	$5.18M	164K	+164,466	NEW	$31.50	Q1 2014

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.